The Sentinel Initiative: Being proactive is key

The FDA is becoming more proactive in monitoring the safety of drugs. Rather than being caught off guard by safety discoveries the FDA might make, pharma companies have an opportunity to demonstrate results to the FDA that are timely, clear and credible. What steps should...